TY - JOUR T1 - Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C JF - Clin Gastroenterol Hepatol Y1 - 2014 A1 - Z M Younossi A1 - Stepanova, M. A1 - Henry, L. A1 - E J Gane A1 - Ira M. Jacobson A1 - E J Lawitz A1 - David R. Nelson A1 - Gerber, L. A1 - Nader, F. A1 - Hunt, S. KW - Affect KW - analysis KW - Cities KW - clinical trial KW - Clinical Trials KW - Disease KW - Fatigue KW - Florida KW - Genotype KW - genotype 1 KW - HCV KW - Health KW - hepatitis KW - Hepatitis C KW - hepatitis C virus KW - Infection KW - interferon KW - Life KW - Liver KW - Liver Diseases KW - Medicine KW - methods KW - New York KW - New Zealand KW - Patients KW - pegylated KW - pegylated interferon KW - Quality of Life KW - Questionnaires KW - Research KW - Ribavirin KW - sofosbuvir KW - sustained virologic response KW - Texas KW - therapy KW - Time KW - treatment KW - Work VL - 12 SP - 1349-1359 IS - 8 ER -